11,625
Participants
Start Date
July 10, 2022
Primary Completion Date
July 1, 2025
Study Completion Date
July 1, 2030
EBV antibodies test
ELISA test of VCA-IgA，EBNA1-IgA，EA-IgA， Zta-IgA ，Rta-IgG and BNLF 2b in nasopharyngeal brushing and plasma
EBV DNA test
quantitative polymerase chain reaction, CRISPR-associated protein 12a and target sequencing of EBV DNA in nasopharyngeal brushing and plasma
RECRUITING
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou
Wuzhou Red Cross Hospital
OTHER
Zhongshan People's Hospital, Guangdong, China
OTHER
Hunan Cancer Hospital
OTHER
The Third Affiliated Hospital of Nanchang University
OTHER
First People's Hospital of Foshan
OTHER
Yuebei People's Hospital
OTHER
Xiangya Hospital of Central South University
OTHER
Changsha Central Hospital
OTHER
Sun Yat-sen University
OTHER